Royce & Associates’s NeueHealth NEUE Stock Holding History

Royce & Associates’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-521	Closed	-$81K	–	993
2022 Q1	$81K	Buy	+521	New	+$116K	﹤0.01%	951

Other funds holding NEUE

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return

Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Royce & Associates's NEUE Position: Q2 2022 in Review

Royce & Associates sold out of NeueHealth (NEUE) in Q2 2022, closing a stake of 521 shares — an estimated $81K sold.

Royce & Associates first reported a position in NEUE in Q1 2022 and held it in 1 quarter. The position peaked at $81K in Q1 2022. 128 funds tracked by Wall St. Rank hold NEUE as of Q2 2022.

Royce & Associates reported no remaining NeueHealth position as of Q2 2022 after selling out during the quarter.
Royce & Associates sold 521 NeueHealth shares in Q2 2022, an estimated $81K.
Royce & Associates first reported a position in NeueHealth in Q1 2022 and held it in 1 quarter.
Royce & Associates's NeueHealth position peaked at $81K in Q1 2022.
128 funds tracked by Wall St. Rank held NeueHealth as of Q2 2022.

Based on Royce & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.